SecBot SecBot

REVBW

REVELATION BIOSCIENCES, INC.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001810560 Biotech & Drug Discovery
Warrants of REVELATION BIOSCIENCES, INC. · REVB stock page →
No price
Market cap
$2.3K
Nano cap
1 year
+8.2%
from $3.53 · Nov 17
30 days
+16.4%
from $3.28
52-week range
$3.20–26.57
−86% from high · low Dec 31
Avg volume 20D
21.6K
Oct 20 spike 156.0K
Short interest
2.1K
≈0.3% of shares · −6.6%
Days to cover
1.0
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 1 trimmed or exited.

  • Short sellersSTEADY

    Short interest −6.6% to 2.1K shares. 1.0 days to cover, ≈0.3% of shares.

  • TrendDOWNTREND

    25% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCTRIM18,716$116.00
UBS Group AGDOUBLED3,532$28.00
UBS Group AGDOUBLED1,300$16.00
UBS Group AGNEAR_EXIT272$3.00
WOLVERINE ASSET MANAGEMENT LLCDOUBLED54,752$383.00
Walleye Capital LLCNEAR_EXIT10,074$71.00
CITADEL ADVISORS LLCTRIM29,400$423.00
WOLVERINE ASSET MANAGEMENT LLCTRIM22,202$333.00

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Oct 20, 2026 Trading halt
Halt Resumed: REVBW, trading resumed after T3 (News and Resumption Times)
Halted 2026-10-19T23:50:00.000Z | Resumed 2026-10-20T13:05:00.000Z
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC · TRIM
18,716 shares ($116.00)
Jun 30, 2026 Inst.
UBS Group AG · DOUBLED
3,532 shares ($28.00)
Jun 1, 2026 SEC
Revelation Biosciences, Inc. filed an 8-K on June 1, 2026, announcing the release of an updated corporate presentation…
8-K · Impact 2/10

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All REVBW filing & press-release reports (1)